Gilead Sciences To Acquire Cell Therapy Company in $567-Million Deal
By

By
Gilead Sciences and its cell-therapy subsidiary, Kite Pharma, have agreed to acquire Cell Design Labs, an Emeryville, California-headquartered company specializing in cell therapies and related technologies, for $567 million. The…

WuXi Biologics Opens Biologics Mfg Facility
By

By
WuXi Biologics, part of WuXi AppTec, a contract service provider, has opened its cGMP biologics manufacturing facility in Wuxi, China for full operations. In April 2015, WuXi Biologics announced a…

FDA Commissioner Announces New Digital Health Policies
By

By
The US Food and Drug Administration (FDA) has released three new digital health policy documents to outline the FDA’s approach in the development and oversight of digital health tools. FDA…

Roche Divests Solid-Dosage Mfg Facility to Recipharm
By

By
Roche has completed its previously announced sale of its solid-dosage manufacturing facility in Leganés, Spain to Recipharm, a Jordbro, Sweden-headquartered contract development and manufacturing organization. In September 2017, Roche signed…

Sanofi and Shire Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Sanofi and Shire. Editor’s Note: This article was updated on a continuous basis…

Mylan, Merck & Co., and Lilly Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Mylan, Merck & Co., Lilly, and Amgen. Editor’s Note: This article was updated on a…

Ardelyx, Kyowa Hakko Kirn Partner
By

By
Ardelyx, a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, and Kyowa Hakko Kirin, a Japan-based pharmaceutical company, have signed a license agreement that provides Kyowa Hakko Kirin with…

SCA Pharmaceuticals Expands Operations
By

By
SCA Pharmaceuticals, a Little Rock, Arkansas-headquartered company specializing in sterile compounding, has opened a 90,000-square-foot manufacturing facility in Windsor, Connecticut. SCA is an FDA 503B outsourcing facility providing sterile admixtures…

German Regulators Approve Corrective Plan for Dr. Reddy’s Dosage-Form Plant
By

By
German regulatory authorities have approved Dr. Reddy’s Laboratories’ corrective and preventive action plan for its formulations manufacturing facility in Duvvada, Visakhapatnam, India. Consequently, German regulatory authorities have permitted production to…

The Medicines Company to Sell Infectious Disease Business to Melinta
By

By
The Medicines Company, a Parsippany, New Jersey-based pharmaceutical company, has agreed to sell its infectious disease business unit to Melinta Therapeutics, a New Haven, Connecticut-based biopharmaceutical company, for $270 million…